Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease

INTRODUCTION: Patients with hepatitis C virus (HCV) infection and chronic kidney disease (CKD) are a high-priority population for treatment. METHODS: We performed a post hoc pooled efficacy and safety analysis that included HCV genotype 1–infected patients with compensated liver disease and CKD stag...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Kidney Int Rep
Egile Nagusiak: Bernstein, David E., Tran, Albert, Martin, Paul, Kowdley, Kris V., Bourliere, Marc, Sulkowski, Mark S., Pockros, Paul J., Renjifo, Boris, Wang, Deli, Shuster, Diana L., Cohen, Daniel E., Jacobson, Ira M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2018
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6365509/
https://ncbi.nlm.nih.gov/pubmed/30775621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2018.10.005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak